Clinical trials
Terminated Squamous Cell Carcinoma of Head and Neck trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2012 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 3 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| Amgen | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Incyte Corporation | 1 |
| Ipsen | 1 |
| Leiden University Medical Center | 1 |
| PCI Biotech AS | 1 |
| Sanofi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Squamous Cell Carcinoma of Head and Neck | 9 |
| Head and Neck Neoplasms | 3 |
| Colorectal Neoplasms | 2 |
| Neoplasms | 2 |
| Recurrence | 2 |
| Adenocarcinoma of Lung | 1 |
| Bone Neoplasms | 1 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Ovarian Epithelial | 1 |
| Carcinoma, Squamous Cell | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.